Announcements Trials
Browse Landscape

Phase

Phase 2 48Phase 1 24Phase 3 22Phase 1/2 17Phase NA 7Phase 2/3 1

Status

Unknown 24Completed 23Recruiting 17Terminated 11Withdrawn 7Not yet recruiting 3Active not recruiting 3Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 2Genitourinary 1

Conditions

Carcinoma, Hepatocellular 2Paranasal Sinus Neoplasms 1Ototoxicity 1Neoplasms 1Nasopharyngeal Carcinoma 1Infiltrating Bladder Urothelial Carcinoma 1Head and Neck Neoplasms 1

Interventions

Radiosurgery 20Magnetic Resonance Spectroscopy 20Exercise 15Biopsy 11Surveys and Questionnaires 9Standard of Care 9Cyclophosphamide 9Educational Status 8Practice Guidelines as Topic 7Doxorubicin 7Cisplatin 7Therapeutics 6Radiotherapy 6Methods 6Fluorodeoxyglucose F18 6Early Intervention, Educational 6Blood Specimen Collection 6Radiotherapy, Intensity-Modulated 5Electroporation 5Cryosurgery 5Colonoscopy 5X-Rays 4Water 4Vincristine 4Polymerase Chain Reaction 4Palliative Care 4Irinotecan 4Drug Therapy 4Diet Therapy 4Cryotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × Cisplatin × Clear all
NCT01326468 2025-09-25

Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

Thomas Jefferson University

Phase NA Withdrawn
Head & Neck

Head and Neck Neoplasms

NCT02289807 2021-10-15

Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy

Sun Yat-sen University

Phase NA Withdrawn
Head & Neck

Nasopharyngeal Carcinoma

NCT02944357 2017-11-17

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

Mayo Clinic

Phase NA Withdrawn
Genitourinary

Infiltrating Bladder Urothelial Carcinoma

NCT02382068 2017-11-09

Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

Ohio State University Comprehensive Cancer Center

Phase NA Withdrawn

Ototoxicity, Neoplasms

NCT01857726 2016-04-28

Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion

Seoul National University Hospital

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT00746655 2015-12-24

SBRT + TACE for Primary Hepatocellular Carcinoma

University of Pittsburgh

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT00347256 2008-12-10

Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer

University of Tennessee

Phase NA Withdrawn
60 enrolled

Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡